Illuminata, Inc. - Shining light on questions about research with human subjects.
Illuminata's Home Page About Illuminata News in Research With Human Subjects Continuing Education Resources Online Resources for Human Subjects Review Contact Information for Illuminata


News In Research With Human Subjects for 2003 through 2005 (Articles are listed most recent first.)
Return to Main Page for News In Research With Human Subjects
 
For information about how to have the news delivered weekly to your email inbox
and to receive a FREE 4 week trial subscription, click here.
 
Week of December 26, 2005
Editorial Retraction: Jung and Hyun, Oocyte and somatic cell procurement for stem cell research: The South Korean experience, American Journal of Bioethics 6: W19-W22, January/February 2006
Patient-Centered Informed Consent in Surgical Practice, Bernat and Peterson, Archives of Surgery 141:86-92, January 2006 (abstract freely available)
Informing research participants of research results: analysis of Canadian university based research ethics board policies, MacNeil and Fernandez, Journal of Medical Ethics 32: 49-54, Jan 1, 2006 (abstract freely available)
Equitable treatment for HIV/AIDS clinical trial participants: a focus group study of patients, clinician researchers, and administrators in western Kenya, Shaffer et al., Journal of Medical Ethics 32: 55-60, Jan 1, 2006 (abstract freely available)
Brief report on the experience of using proxy consent for incapacitated adults, Mason et al., Journal of Medical Ethics 32: 61-62, Jan 1, 2005 (abstract freely available)
The Ethics of Industry Experimentation Using Employees: The Case of Taste-Testing Pesticide-Treated Tobacco, McDaniel et al. American Journal of Public Health 96: 37-46, Jan 1, 2006 (abstract freely available)
Faster probe sought into research trials, Seattle Times, Dec 31, 2005
"The chairman of the Senate committee that oversees the Securities and Exchange Commission is prodding the agency to accelerate its investigation into the trafficking of clinical research trials information between doctors and Wall Street…"
Establishment and Operation of Clinical Trial Data Monitoring Committees, US FDA Center for Biologics Evaluation and Research, Dec 30, 2005
"This guidance discusses the roles, responsibilities and operating procedures of Data Monitoring Committees (DMCs) (also known as Data and Safety Monitoring Boards (DSMBs))…This guidance finalizes the draft guidance entitled "Guidance for Clinical Trial Sponsors: On the Establishment and Operation of Clinical Trial Data Monitoring Committees" dated November 2001…"
S. Korean School Debunks Hwang's Research, The San Francisco Chronicle, Dec 29, 2005
"South Korea's top university said Thursday that a leading researcher fabricated all of the stem cells he said were cloned from individual patients — a shattering blow to the disgraced scientist's reputation as a medical pioneer…"
Drug-trial registry data grows, but report faults some firms, Boston Globe, Dec 29, 2005
"Drug companies are making public more information about medical studies they are conducting, but some still withhold key details, a new analysis of a federal registry finds…"
Trial Registration at ClinicalTrials.gov between May and October 2005, Zarin et al., New England Journal of Medicine 353, Dec 29, 2005 (full text freely available)
Trial Registration at ClinicalTrials.gov between May and October 2005, Zarin et al., New England Journal of Medicine 353, Dec 29, 2005 (full text freely available)
Editorial: Trial Registration Report Card, Drazen and Wood, New England Journal of Medicine 353, Dec 29, 2005 (full text freely available)
Editorial: Registries and Registration of Clinical Trials, Haug et al., New England Journal of Medicine 353, Dec 29, 2005 (full text freely available)
 
Week of December 19, 2005
AIDS whistleblower reinstated, Monterey County Herald, Dec 24, 2005
"Reversing course, the government's premier health research agency has reinstated a medical safety expert who was fired after raising allegations of scientific misconduct and sexual harassment in federal AIDS research, his lawyer said Friday…"
South Korean researcher resigns after university says he faked stem cell research, San Diego Union Tribune, Dec 23, 2005
"South Korean researcher Hwang Woo-suk resigned from his university on Friday after the school said he fabricated stem-cell research that had raised hopes of new cures for hard-to-treat diseases…"
US research 'endangered Amazon villagers', The Guardian UK, Dec 20, 2005
"Health officials in Brazil have launched an investigation after claims that at least 10 impoverished Brazilians from an Amazon village may have contracted malaria while being used as human "guinea pigs" during a study by an American university…"
 
Week of December 12, 2005
Indy drivers aid military with crash research, MSNBC, Dec 17, 2005
"…Embedded inside was a tiny device used to detect and quantify the forces that pummel drivers during crashes. Air Force scientists are collecting the data to develop safer helmets, harnesses and ejection seats for military pilots…"
South Korean stands by his stem cell research, Seattle Times, Dec 16, 2005
"…Hwang Woo-suk apologized for "fatal errors and loopholes in reporting the scientific accomplishment" and said he has asked that the scientific article outlining his research be withdrawn…"
SFBC refutes magazine charges, Miami Herald, Dec 15, 2005
"In a 19-page letter to a U.S. senator scheduled to be released today, two outside counsels hired by SFBC International, the Miami drug-testing company, disputed much of the information in a recent negative magazine article, but said one executive's behavior was ''inappropriate'' in threatening test subjects who talked to reporters. The letter also recommends Congress adapt a database of persons who volunteer for drug tests so that subjects can't jump from one drug test to another without the testing companies knowing…"
Report to Senator Grassley from Independent Counsel to the Board of Directors of SFBC International Inc, Concerning Allegations Related to SFBC In Bloomberg’s Nov 2, 2005 Article, SFBC International Web Site, Dec 12, 2005 (no longer available)
SFBC Drug Testers Have Tuberculosis After Exposure at Center, Bloomberg, Dec 15, 2005
"…SFBC, which runs the largest clinical trial site in North America, kept Mohsen and his roommate together for another four days, says SFBC lawyer Michael York. In November, Mohsen learned that his roommate had active tuberculosis, and that Mohsen himself had contracted latent tuberculosis. Eight other participants in the September SFBC drug trial also tested positive for latent tuberculosis, according to the Montreal Regional Health Department…"
Researcher tries to distance himself from cloning work, Seattle Times, Dec 14, 2005
"Some of stem-cell researcher Hwang Woo-suk's high-profile human cloning work announced earlier this year may have been "fabricated," a former top collaborator charged as he attempted to distance himself from the groundbreaking research…"
Spanish Web Page, Office for Human Research Protections(OHRP) Web Site, Dec 13, 2005
The Office for Human Research Protections has recently launched its new Spanish web page. The Spanish web page includes:
  • 45 CFR 46, subparts A, B, C, and D
  • Step-by-Step Instructions to Register an IRB
  • Instructions for IRB Updates
  • Terms of the Federalwide Assurance (FWA)
  • Step-by-Step Instructions for an FWA application
  • Instructions for FWA Updates
Fraud earns researcher time in jail, The Scientist, Dec 13, 2005
"A Veterans Administration researcher based in New York was sentenced to almost 6 years in jail after he admitted to doctoring patient test results – an extreme punishment for an extreme crime, experts say…"
Human brain cells working in mice, The Seattle Times, Dec 13, 2005
"By injecting human embryonic stem cells into the brains of fetal mice inside the womb, scientists in California have created living mice with working human brain cells…Reflecting growing concerns about the ethics of making animal-human hybrids, the National Academy of Sciences earlier this year released voluntary guidelines on chimera research that have been adopted by major research institutes and have been made mandatory in California for state grant recipients…"
Guidelines for Human Embryonic Stem Cell Research, Committee on Guidelines for Human Embryonic Stem Cell Research, National Research Council, April 26, 2005 (full report freely available)
When researchers are the guinea pigs. Should scientists be allowed to continue studying themselves?, Boston Globe, Dec 12, 2005
"…Self-experimentation, though controversial, is a tradition that dates back centuries… But the ethical issues surrounding such research remain unresolved…"
 
Week of December 5, 2005
Behavioral and Social Issues Among Volunteers in a Preventive HIV Vaccine Trial in Thailand, Jenkins et al., Journal of Acquired Immune Deficiency Syndromes 40, Dec 15, 2005 (abstract freely available)
Assessing the Attitudes, Knowledge, and Awareness of HIV Vaccine Research Among Adults in the United States, Allen et al., Journal of Acquired Immune Deficiency Syndromes 40, Dec 15, 2005 (abstract freely available)
Designing research in vulnerable populations: lessons from HIV prevention trials that stopped early, Mills et al. British Medical Journal 331: 1403-1406, Dec 10, 2005 (abstract freely available)
Payment to healthcare professionals for patient recruitment to trials: a systematic review, Bryant and Powell, British Medical Journal 331: 1377-1378, Dec 10, 2005 (abstract freely available)
Journal: Bad Vioxx outcomes not disclosed, Boston Globe, Dec 8, 2005
"Authors of a study funded by Vioxx maker Merck & Co. failed to disclose in a report published in the New England Journal of Medicine in 2000 that three additional patients in a clinical study suffered heart attacks while using the now-withdrawn painkiller, the journal wrote in an editorial released Thursday…"
Editorial: Expression of Concern: Bombardier et al., "Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis," N Engl J Med 2000;343:1520-8, Curfman et al., New England Journal of Medicine, early publication, Dec 8, 2005 (scheduled to be freely available until Dec 29, 2005)
Press Release: Human Research Protection Award Recipients Announced, Dec 8, 2005
"Winners of the 2005 Award for Excellence in Human Research Protection were announced today by Dr. Peter G. Goldschmidt, President and Founder of the Health Improvement Institute…"
Study Debunks That Blacks Are Wary of Medical Research, Washington Post, Dec 6, 2005 (free one time registration required)
"…Given the chance to participate, minorities volunteer at least as often as whites do, according to the first study to measure response rates directly. And although minorities are indeed underrepresented in research, the reason appears to be that doctors and scientists reach out to them less…"
Are Racial and Ethnic Minorities Less Willing to Participate in Health Research?, Wendler et al. Public Library of Science (PLoS) Medicine 3, published online Dec 6, 2005
Ethical concerns on face transplant grow, New York Times, Dec 6, 2005 (scheduled to be freely available until Dec 12, 2005, still available)
"In urgent telephone calls and agonized e-mail messages, American scientists are expressing increasing concerns that the world's first partial face transplant, performed in northern France on Nov. 27, may have been undertaken without adequate medical and ethical preparation…"
Oocyte and Somatic Cell Procurement for Stem Cell Research, Kyu Won Jung and Insoo Hyun, American Journal of Bioethics 5, Nov/Dec 2005 (full article freely available)
A Commentary on Oocyte Donation for Stem Cell Research in South Korea, Magnus and Cho, American Journal of Bioethics 5, Nov/Dec 2005 (full article freely available)
 
Week of November 28, 2005
All Multiple Project Assurances (MPA) and Cooperative Project Assurances (CPA) with the Department of Health and Human Services Expire December 31, 2005, OHRP News, OHRP Web Site, Dec 2, 2005
"…Since February 10, 2005, the FWA is the only type of assurance accepted for review and approval by OHRP. Institutions still holding a Multiple Project Assurance (MPA) or a Cooperative Project Assurance (CPA) have until December 31, 2005, to convert to the FWA if an OHRP-approved assurance of compliance is still required. Single Project Assurances (SPA) currently approved by OHRP will remain in effect for the duration of the project and through all non-competitive award renewals. To date, 96% (510) of the institutions holding an OHRP-approved MPA have converted to the FWA. However, only 58% (1,177) of the institutions holding an OHRP-approved CPA have converted to the FWA…On January 1, 2006, any institution that has not obtained an OHRP -approved FWA will no longer be covered by an OHRP -approved assurance of compliance, and therefore, any ongoing HHS-supported human subjects research at such an institution that is not exempt will need to be suspended until the institution submits, and OHRP approves, an FWA"
Amid concerns of quality, ethics, biotech firm answers China's call, Pioneer Press, Dec 2, 2005
"…Excorp joins growing numbers of medical companies heading to emerging countries such as China and India, either to reach large new patient markets or to cut costs on notoriously expensive, lengthy clinical trials for their products — or both, as in Excorp's case. It's a shift that's raising concerns among medical ethicists as well as some drug-development professionals who worry about whether emerging countries can meet U.S. standards for human testing. There are no international regulations for running human clinical trials, only guidelines…"
Children’s understanding of the risks and benefits associated with research, Burke et al. Journal of Medical Ethics 31: 715-720, Dec 1, 2005 (abstract freely available)
Parental preferences for neonatal resuscitation research consent: a pilot study, Culbert and Davis, Journal of Medical Ethics 31: 721-726, Dec 1, 2005 (abstract freely available)
Informed consent and participant perceptions of influenza vaccine trials in South Africa, Moodley et al., Journal of Medical Ethics 31: 727-732, Dec 1, 2005 (abstract freely available)
Quantitative aspects of informed consent: considering the dose response curve when estimating quantity of information, Lynöe and Hoeyer, Journal of Medical Ethics 31: 736-738, Dec 1, 2005 (abstract freely available)
The ethics of research using electronic mail discussion groups, Kralik et al., Journal of Advanced Nursing 52: p. 537, December 1, 2005 (abstract freely available)
Partial Face Transplant Done in France, The San Francisco Chronicle, Nov 30, 2005
"Doctors in France said they had performed the world's first partial face transplant, forging into a risky medical frontier with their operation on a woman disfigured by a dog bite…"
 
Week of November 21, 2005
Cloning master apologizes, quits, Seattle Times, Nov 25, 2005
"Hwang Woo-suk, a stem-cell pioneer whose South Korean team cloned the first human embryo and created the first cloned dog, publicly apologized Thursday for ethical breaches at his lab and said he would resign from all his official posts…"
HHS weighs relaxing restrictions on inmate testing, GovExec.com, Nov 23, 2005
"Officials at the Department of Health and Human Services are considering whether to loosen federal patient protections for prisoners, in order to allow more inmates to volunteer for medical experiments and social-science research…"
Ethical Considerations for Revisions to the DHHS Regulations for Protection of Prisoners Involved in Research, Institute of Medicine Project Web Page
S. Korean Stem Cell Team Paid Women for Eggs, Washington Post, Nov 22, 2005 (free one time registration required)
"The head of a Seoul fertility clinic associated with an embattled Korean stem cell researcher said yesterday that he paid 16 women for their eggs, according to a South Korean newspaper report…"
Ex-VA Researcher Sentenced in Drug Scandal, Seattle Post-Intelligencer, Nov 21, 2005 (no longer available)
"A former cancer researcher at a Veterans Affairs hospital was sentenced Monday to nearly six years in prison for criminally negligent homicide in the death of an Air Force veteran enrolled in a drug experiment…"
Harvard hopes database will speed cancer cures, The Boston Globe, Nov 21, 2005
"…Now the Harvard hospitals are establishing a "virtual specimen locator" to encourage sharing among researchers and speed up discovery of life-saving cancer screening tests and treatments -- a concept they hope to expand to the University of California, Los Angeles, the University of Pittsburgh, and the University of Indiana School of Medicine…The project faces a number of ethical and legal hurdles because the hospitals must develop ways to protect patients' identities, as information about them and their tumors rockets around the country via the Internet…"
 
Week of November 14, 2005
Three drug testers claim SFBC threatened them, Seattle Times, Nov 20, 2005
"SFBC International, which runs the largest private drug-test center in North America, threatened to arrange federal deportation of Latin American immigrants who disclosed health risks in clinical trials, according to people who participated in the company's Miami-based experiments…"
Women stay in bed for 60 days … for science, MSNBC, Nov 20, 2005
"…The joint study by the European Space Agency, the French space agency CNES, the Canadian Space Agency and NASA will fill in unknowns about how to protect women astronauts from the dramatic physical side effects of weightlessness…"
Secretary’s Advisory Committee on Human Research Protections (SACHRP) November 1 - 2, 2005 Meeting, Meeting Agenda, Presentation Materials and Meeting Transcripts, Office for Human Research Protections (OHRP) Web Site, posted Nov 18, 2005
Pediatric Obesity Devices Should Be Tested First In Children With Serious Co-Morbidities, Cmte. Says, FDAAdvisoryCommittee.com, Nov 18, 2005
"Children initially enrolled in trials for devices that treat obesity should have a serious co-morbidity, members of FDA’s Pediatric Advisory Committee concurred…"
After The Disaster, Research Booms, CBS News, Nov 18, 2005
"…quick on the heels of relief workers come the disaster researchers - people who leave the ivory tower of academia and head to the scene, hoping their analyses can improve people's lives the next time calamity strikes…"
Lives that depend on studies in labs, The Hindu, India, Nov 16, 2005
"…While free medicine, medical attention and the promise of better health are luring several ailing persons to clinical trials, the offer of money is luring more healthy persons to volunteer for bio-equivalence studies, where clinical research organisations (CRO) evaluate the standard of the generic drug against the patented drug…"
'Stem cell hub' cloning network project folding. U.S. organizer cites 'misrepresentations' by plan's collaborators in South Korea, The San Francisco Chronicle, Nov 15, 2005
"A global consortium designed to pursue a controversial type of stem cell research involving cloned embryos is collapsing amid ethical questions surrounding human egg donations in South Korea…"
Appropriate Pediatric Age For Obesity Device Trials Will Be Discussed By Cmte., FDAAdvisoryCommittee.com, Nov 15, 2005
"The appropriate age for children enrolling in obesity device trials and their ability to assess the risk-benefit of the procedures will be among the questions discussed at the Nov. 16-17 meeting of FDA's Pediatric Advisory Committee…"
Chips spark ethics concerns, The Chattanooga Times Free Press, Nov 14, 2005 (no longer available)
"Medical ethics experts are questioning a proposal to implant medical identification microchips in the arms of developmentally disabled clients at Orange Grove Center…"
 
Week of November 7, 2005
Fighting For A Miracle, CBS News, Nov 13, 2005
"For many people with a terminal illness, their last hope may come from a drug that is not widely available…The only way to get such a drug is through a government approved clinical trial. But now some patients, their families and doctors say that clinical trials in terminally ill patients may be killing more people than saving…"
What do people at risk for Alzheimer disease think about surrogate consent for research? Kim et al. Neurology 65: 1395-1401, Nov 8, 2005 (abstract freely available)
Private tests a risky business, Seattle Times, Nov 7, 2005
"…The U.S. Food and Drug Administration has farmed out much of the oversight for protecting people in tests to private companies such as Western. WIRB monitors clinical trials for more than half the new drugs submitted each year to the FDA…"
 
Week of October 31, 2005
Human guinea pigs pay for lax FDA rules, Seattle Times, Nov 6, 2005
"…Across the U.S., 3.7 million people have enrolled in drug tests sponsored by the world's largest pharmaceutical companies…At the same time, the U.S. Food and Drug Administration has farmed out much of the responsibility for overseeing safety in these tests to private companies known as institutional review boards. These boards are also financed by pharmaceutical companies. So, the drug industry is paying the people who do the tests — and most of the people who regulate those tests…"
War hero died at clinic with history of neglect, Seattle Times, Nov 6, 2005
"…Polsgrove enrolled in a clinical trial for clozapine, a schizophrenia drug being tested for Ivax, the largest U.S. maker of generic drugs based in Miami…A day after he took the first dose, Polsgrove's heartbeat became irregular, according to a January 2005 letter to Fabre from the U.S. Food and Drug Administration…"
India plans to audit clinical trials, Mudur, British Medical Journal 331: 1004, Nov 5, 2005 (abstract freely available)
"The Indian government has announced a plan to set up a registry and to audit some clinical trials after being dogged for years by controversies over illegal and unethical trials…"
Review: Randomized Trials Stopped Early for Benefit: A Systematic Review, Montori et al., Journal of the American Medical Association 294:2203-2209, Nov 2, 2005 (abstract freely available)
Editorial: When (Not) to Stop a Clinical Trial for Benefit, Pocock, Journal of the American Medical Association 294: 2228-2230, Nov 2, 2005 (abstract freely available)
Study: Drug testing halted by early success doesn't help patients, USA Today, Nov 1, 2005
"There are many reasons to stop testing a promising new medical treatment early, but patients seldom benefit from the decision, a study reports today…"
Review: Randomized Trials Stopped Early for Benefit: A Systematic Review, Montori et al., Journal of the American Medical Association 294:2203-2209, Nov 2, 2005 (abstract freely available)
"Hello, hello—it’s English I speak!": a qualitative exploration of patients’ understanding of the science of clinical trials, Stead et al. Journal of Medical Ethics 31: 664-669, Nov 1, 2005 (abstract freely available)
How to handle informed consent in longitudinal studies when participants have a limited understanding of the study, Helgesson et al. Journal of Medical Ethics 31: 670-673, Nov 1, 2005 (abstract freely available)
Keep people informed or leave them alone? A suggested tool for identifying research participants who rightly want only limited information, Eriksson et al. Journal of Medical Ethics 31: 674-678, Nov 1, 2005 (abstract freely available)
Special Issue: The Ethical Conduct of Resuscitation Research, Proceedings of the 2005 AEM Consensus Conference, Academic Emergency Medicine 12, November 2005 (Table of Contents; abstracts and extracts freely available)
Hopeful patients crash S.Korea stem cell Web site, Reuters, Oct 31, 2005 (no longer available)
"…The stem cell bank began accepting on-line applications on Tuesday and its Web site (www.worldstemcellhub.org) and telephone lines have been stretched to their limits as patients and their families ask to be included in the research, bank officials said…"
American Association of Medical Colleges (AAMC) Adopts New Principles for Reporting Results of Clinical Trials, AAMC Web Site, Oct 31, 2005
"…The new principles are the product of a working conference convened by the AAMC in June…Participants were charged with drafting a set of comprehensive guidelines that would direct the ethical and operational aspects of data access, analysis, and reporting of clinical research studies. The principles aim to ensure that academic institutions not accept restrictions by sponsors that would exclude members of academic research teams from full intellectual participation in studies and thereby prevent those investigators from being held responsible and accountable for the results…"
Principles for Protecting Integrity in the Conduct and Reporting of Clinical Trials, American Association of Medical Colleges, Sept 15, 2005 (pdf file)
 
Week of October 24, 2005
Controversial Study Allows Parents to Pick Baby's Sex, ABC News, Oct 26, 2005
"Now, doctors at Houston's Baylor College of Medicine are conducting a "sex selection" study that will allow couples to make that wish come true — letting them actually pick their baby's gender…The whole idea of picking a baby's sex is so controversial, it took nine years for researchers to get permission to conduct the study…"
Commentary: The Declaration of Helsinki: an update on paragraph 30, Blackmer and Haddad, Canadian Medical Association Journal 173: 1052-1053, Oct 25, 2005 (full article freely available)
Effect of a Clinical Trial Alert System on Physician Participation in Trial Recruitment, Embi et al., Archives of Internal Medicine165:2272-2277, Oct 24, 2005 (abstract freely available)
Comment: Research and clinical ethics after the tsunami: Sri Lanka, Sumathipala and Siribaddana, Lancet 366:1418-1420, Oct 22, 2005 (free one time registration required; full text freely available)
 
Week of October 17, 2005
Patients turn guinea pigs minus cover, Calcutta Telegraph, India, Oct 23, 2005
"Neither government regulators nor ethics watchdogs in India have adequately equipped themselves to protect the interests of patients who volunteer for clinical trials of new and unproven treatment, clinical research experts have said… gaps in the skills of researchers and ethics committees have created the potential for exploitation of vulnerable sections of patients…"
Viewpoint: HIV prevention research in a resource-limited setting: the experience of planning a trial in Cambodia, Page-Shafer et al., Lancet 366:1499-1503, Oct 22, 2005 (free one time registration required; full text freely available)
Study cites health risks of diabetes drug, Seattle Times, Oct 21, 2005
"A new diabetes drug on track to win approval from the Food and Drug Administration (FDA) more than doubles the risk of death, heart attack and stroke, a finding that renews concerns about the government's safety screening for new medications…"
Effect of Muraglitazar on Death and Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus, Nissen et al. Journal of the American Medical Association Early Release, Oct 20, 2005 (abstract freely available)
Editorial: Selling Safety--Lessons From Muraglitazar, Brophy, Journal of the American Medical Association Early Release, Oct 20, 2005 (extract freely available)
Effects of Hurricanes Katrina and Rita on IRB Operations, Office for Human Research Protections, Oct 20, 2005
"OHRP understands that the effects of Hurricanes Katrina and Rita have been devastating to areas in Louisiana, Texas, Alabama and Mississippi, and as a result, some human subject protection programs at institutions in the affected areas are unable to function, and may be unable to for some time. OHRP has prepared information to help institutions and institutional review boards (IRBs) manage the hurricanes' impact on oversight of research and research subject interventions…"
Press Release: UNESCO’s General Conference adopts Universal Declaration on Bioethics and Human Rights, UNESCO Web Site, Oct 19, 2005
"…framework of principles and procedures that can guide Member States in the development of national policies, legislation and codes of ethics…"
Universal Declaration on Bioethics and Human Rights, UNESCO, Oct 19, 2005
Koreans plan to create 100s of stem cell lines, San Francisco Chronicle, Oct 19, 2005
"Several U.S. researchers already are lined up to participate… Some leading biomedical centers, including Stanford University and UCSF, were recruited to participate but so far have declined, citing reservations about the project's legal and bioethical framework…"
Perspective: An Offshore Haven for Human Embryonic Stem-Cell Research? Okie, New England Journal of Medicine 353:1645-1649, Oct 20, 2005 (extract freely available)
 
Week of October 10, 2005
A Second Chance at Survival, Wilkes Barre Times-Leader, Oct 16, 2005
"A patient turns to an experimental gene drug being tested at Penn to try to stop a deadly cancer…"
ESRC announces research ethics framework, ResearchResearch, UK, Oct 14, 2005
"The Economic and Social Research Council has announced a new research ethics framework for social sciences research, which will take effect from 1 January…"
Economic and Social Research Council Research Ethics Framework, October 2005 (pdf file)
Translational and Clinical Science — Time for a New Vision, Zerhouni, New England Journal of Medicine, 353:1621-1623, Oct 13, 2005 (full text freely available)
Audio interview with Dr. Elias Zerhouni (freely available, Macromedia Flash Player required)
OHRP Compliance Oversight Activities: Significant Findings and Concerns of Noncompliance, Division of Compliance Oversight, Office for Human Research Protections (OHRP ), Oct 12, 2005 (pdf file)
"This document provides a list of significant findings that OHRP has made and concerns that have been expressed in compliance oversight determination letters over the last several years…"
Guidance on Reporting and Reviewing Adverse Events and Unanticipated Problems Involving Risks to Subjects or Others, Office for Human Research Protections, Oct 11, 2005 (comments due by Jan 13, 2006)
"The Office for Human Research Protections (OHRP) is soliciting public comment on a draft guidance document for Institutional Review Boards, investigators, research institutions, Department of Health and Human Services agencies that conduct or sponsor human subjects research, and other interested parties…"
Draft Document: Guidance on Reporting and Reviewing Adverse Events and Unanticipated Problems Involving Risks to Subjects or Others, OHRP, Oct 11, 2005
Physicians want transparency as Guidant lawsuits grow, Canadian Medical Association Journal 173: 855-856, Oct 11, 2005
"…Guidant Canada's recall of several models of implantable cardiac defibrillators (ICDs), which was triggered by a front-page New York Times story saying the company had concealed problems with one model for 3 years…"
UW halts enrollment in study after regulators find problems, The Seattle Times, Oct 10, 2005
"The federal government has identified more safety problems with human research at the University of Washington, prompting the school to halt further enrollment in a genetic study…"
 
Week of October 3, 2005
When the Doctors Are Their Own Best Guinea Pigs, The New York Times, Oct 9, 2005 (archived, payment required)
"…How many other Dr. Marshalls are out there - scientists who become their own guinea pigs? No one knows because no one keeps tabs on the number of experiments performed on people in this country or elsewhere…"
S. African university slams "AIDS vitamins" doctor, Reuters, Oct 7, 2005 (no longer available)
"Johannesburg's University of the Witwatersrand (Wits) has demanded Dr Matthias Rath stop what it says are unethical trials of his multivitamins on AIDS sufferers in Cape Town's Khayelitsha township… South Africa's Medicines Control Council (MCC) is probing claims that the foundation is conducting illegal research trials on AIDS victims and that it is urging patients not to take ARVs…"
Ethics Of Leuprolide Test For Puberty Disorders To Be Reviewed By Subcommittee, FDA Advisory Committee, Oct 6, 2005
"A University of Chicago research protocol for a test using leuprolide (TAP’s Lupron) to detect puberty disorders will be reviewed by FDA’s Pediatric Ethics Subcommittee at its Nov. 15 meeting…"
Solicitation of Public Review and Comment on Research Protocol: Gonadotropin-releasing Hormone Agonist Test in Disorders of Puberty. Docket No. 2005N-0404, [Pages 58713-58714 Federal Register Doc. 05-20301] (Comments due November 1, 2005)
Gonadotropin Releasing Hormone (GnRH) Agonist Test in Disorders of Puberty, Protocol, IRB Documents, Study Communications
FAQs on Research Involving Children, Office for Human Research Protections (OHRP) Web Site, Oct 3, 2005
"OHRP announces the availability of a new set of Frequently Asked Questions (FAQs), which help clarify issues related to research involving children…"
 
Week of September 26, 2005
International Compilation of Human Subject Research Protections, second edition, Office for Human Research Protections (OHRP), Oct 1, 2005 (pdf file)
"The Second Edition encompasses 72 countries, lists standards issued by international organizations, includes updated information for General and Drug research, and provides a listing of the laws, regulations, and guidelines on privacy/data protection, human biological materials, and genetic research. The Compilation now provides over 400 direct web links to each country's key organizations and laws, whenever available. OHRP believes this Compilation will help IRBs, researchers, and others to meet regulatory requirements to assure that research studies comply with applicable standards…"
Stroke patients' preferences and values about emergency research, Blixen and Agich, Journal of Medical Ethics 31: 608-611, Oct 1, 2005 (abstract freely available)
Vital research given go ahead by parents, Journal of Medical Ethics 31: 590, Oct 1, 2005 (extract freely available)
Cancer trials delayed by contraceptive objections, Sunday Business Post, Ireland, Oct 1, 2005 (no longer available)
"…questions were raised by a member of the ethics committee at St Vincent's Hospital, Dublin 4,who wanted the stipulation that female cancer patients undergoing clinical trials should use barrier contraceptives removed from the protocol, citing religious grounds…"
Human guinea pigs queue for cash as drug firms rush to India, TODAYonline, Singapore, Sept 30, 2005
"…Critics say India's huge illiterate population is in danger of being misused by unethical firms to test suspect drugs. But industry officials say each trial follows a strict code of ethics…"
Senators Seek FDA Chief Resignation Probe, The San Francisco Chronicle, Sept 29, 2005
"Senators with oversight of the Food and Drug Administration asked for an inspector general's inquiry Thursday into the circumstances surrounding the sudden resignation of the agency's chief…"
Office of Research Integrity (ORI) 2005 Extramural Award Data, ORI Web Site, Sept 28, 2005 (links to all project abstracts)
"Seven awards were made by the Research on Research Integrity (RRI) Program in response to 47 applications received…"
Bioethics 'expertise' comes from all corners, USA Today, Sept 28, 2005
"Any given Sunday morning, a bioethicist somewhere in America suits up for a TV appearance…But who are these people opining on what we should do?…"
Draft Revision of 1991 Council for International Organizations of Medical Sciences (CIOMS) International Guidelines for Ethical Review of Epidemiological Studies, Council for International Organizations of Medical Sciences (CIOMS) Web Site, Sept 28, 2005 (pdf file, comments due end of October 2005)
CIOMS Web Site Home Page
 
Week of September 19, 2005
FDA commissioner abruptly steps down, Seattle Times, Sept 24, 2005
"Food and Drug Administration (FDA) Commissioner Lester Crawford resigned unexpectedly yesterday, two months after he survived a tough Senate confirmation…"
Parents gamble on unproven therapy to give daughter a normal life, Myrtle Beach Sun News, Sept 23, 2005
"Last week, little Ariel Coover lay with her chin tucked to her chest in a bright, white operating room at Cooper University Hospital in Camden, N.J. The only visible part of the 3 1/2-month-old was the top of her bald head, where six catheters protruded like shiny strands of hair…Ariel is the latest and youngest patient in the first clinical gene-transfer study…"
Possible Conflicts for Doctors Are Seen on Medical Devices, Wilmington Morning Star, Sept 22, 2005 (no longer available)
"…in a variety of ways, many doctors have unusually close, if largely unseen, ties to device makers. And those relationships are a central issue on an emerging battleground in the health care wars: the upward cost spiral of implantable medical devices…"
Senate Eyes FDA Conflict of Interest Probe, The San Francisco Chronicle, Sept 21, 2005
"Senators asked Congress' investigative arm Wednesday to look into the Food and Drug Administration's practice of letting scientists serve on its advisory panels even if they have conflicts of interest…"
U.S. Senate votes for more information on FDA panels, Reuters, Sept 21, 2005 (no longer available)
"The Food and Drug Administration would have to disclose the industry ties of advisory committee members 15 days prior to their meetings under a measure passed by the U.S. Senate…"
Drug firms launch Web site to disclose trials data, Reuters, Sept 21, 2005 (no longer available)
"The global pharmaceutical industry launched a new Web site on Wednesday giving details of clinical trials on new medicines, in a bid to allay patient fears over drug safety…"
International Federation of Pharmaceutical Manufacturers and Associations Clinical Trials Portal (launched Sept 21, 2005)
Journal of the American Medical Association Special Issue: Medical Research - State of the Science, JAMA 294, pp. 1307-E8, Sept 21, 2005 (table of contents and abstracts/extracts/full text freely available)
Selected articles include:
Financial Anatomy of Biomedical Research, Moses et al. JAMA 294:1333-1342, Sept 21, 2005 (abstract freely available)
US Biomedical Research: Basic, Translational, and Clinical Sciences, Zerhouni, JAMA 294:1352-1358, Sept 21, 2005 (abstract freely available)
Prospects for the Future of Child Health Through Research, Feigin, JAMA 294:1373-1379, Sept 21, 2005 (abstract freely available)
Public Attitudes and Perceptions About Health-Related Research, Woolley and Propst, JAMA 294:1380-1384, Sept 21, 2005 (abstract freely available)
Consensus and Controversy in Clinical Research Ethics, Brody et al., JAMA 294:1411-1414, Sept 21, 2005
Guidance on Institutional Review Board (IRB) Review of Clinical Trial Websites, Office for Human Research Protections (OHRP) Web Site, Sept 20, 2005
"The guidance, which applies to HHS-conducted or -supported research, describes the circumstances for which IRB review of clinical trial websites is required and provides some points to consider in the review process. It also describes the circumstances for which IRB review of clinical trial websites is not required…"
Requests for Public Comment, OHRP Website, Sept 20, 2005
"OHRP has added a "Requests for Public Comment" section to its website. Simultaneously with the addition of the new website section, OHRP invites public comments on the following…"
OHRP's August 31, 2005 Letter to the National Cancer Institute (NCI) on Conflicting Interest and the Pediatric Central IRB (PedCIRB) (comments due by Dec 15, 2005)
Study: Medical Research Spending Jumps, The San Francisco Chronicle, Sept 20, 2005
"Total U.S. spending on medical research has doubled in the past decade to nearly $95 billion a year, though whether the money is being well spent needs much better scrutiny, a study has found…"
Financial Anatomy of Biomedical Research, Moses et al. JAMA 294:1333-1342, Sept 21, 2005 (full text freely available)
Journal of the American Medical Association Special Issue: Medical Research - State of the Science, JAMA 294, pp. 1307-E8, Sept 21, 2005 (table of contents and abstracts/extracts/full text freely available)
Report: Ethical Considerations for Research on Housing-Related Health Hazards Involving Children, Board on Children, Youth and Families (BCYF) of the National Research Council and the Institute of Medicine, Sept 19, 2005
"In the wake of the Maryland Court of Appeals ruling in the case of Grimes v. Kennedy Krieger Institute, the National Academies was asked to review the challenges and ethical issues in conducting housing-related health hazards research…"
Executive Summary (33 pages, pdf file)
 
Week of September 12, 2005
Dozen to Interview for Chance at New Face, The San Francisco Chronicle, Sept 18, 2005
"In the next few weeks, five men and seven women will secretly visit the Cleveland Clinic to interview for the chance to have a radical operation that's never been tried anywhere in the world… The "consent form" says that this surgery is so novel and its risks so unknown that doctors don't think informed consent is even possible. Here is what it tells potential patients…"
Editorial: Reforming research ethics committees, Ashcroft et al. British Medical Journal 331:587-588, Sept 17, 2005 (extract freely available)
Secretary’s Advisory Committee on Human Research Protections (SACHRP) Agenda and Meeting Materials from Aug 1-2, 2005 Meeting, OHRP Web Site, Sept 16, 2005
Wall Street and Clinical Trials, Steinbrook, New England Journal of Medicine 353:1091-1093, Sept 15, 2005 (extract freely available)
 
Week of September 5, 2005
Panel Backs Drug Amid Conflict Concerns, New York Times, Sept 10, 2005 (free one-time registration required; archived, payment required)
"Questions about potential conflicts of interest continue to dog the federal drug approval process. A Food and Drug Administration advisory panel in Silver Spring, Md., recommended approval yesterday of the Bristol-Myers Squibb diabetes drug, Pargluva…But no cardiologist was present for the vote…"
Open label extension studies: research or marketing?, Taylor and Wainwright, British Medical Journal 331:572-574, Sept 10, 2005 (extract freely available)
Congress investigating Gates Foundation exec, Seattle Times, Sep 9, 2005
"The director of the Gates Foundation's multibillion-dollar global health program, Dr. Richard D. Klausner, is at the center of a congressional investigation into practices within a government agency he once directed…"
Gates Foundation exec quits; says move not tied to federal investigation, Seattle Times, Sept 13, 2005
Bioethics Council Head to Step Down, Washington Post, Sept 9, 2005 (free one-time registration required